Domestic drugs formulations market to be worth Rs 5.5 trn by 2034: Report
Pharma companies expected to expand portfolios by focusing on lifestyle disease therapies, it says
Pharma companies expected to expand portfolios by focusing on lifestyle disease therapies, it says